← FDA DRUG APPROVALS

FDA ANDA · ANDA202689

VOLNEA

desogestrel and ethinyl estradiol

Sponsor: XIROMED

APPLICATION
ANDA202689
TYPE
ANDA
ORIGINAL APPROVAL
2016-09-09
LATEST ACTION
2024-05-15
ROUTE
ORAL-28
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

VOLNEAPrescription
DESOGESTREL 0.15MG,N/A, ETHINYL ESTRADIOL 0.02MG,0.01MG · TABLET · ORAL-28

Approval history

2024-05-15Labeling · Supplement 6 · standardAP
2022-04-29Labeling · Supplement 5 · standardAP
2017-08-09Labeling · Supplement 1 · standardAP
2016-09-09UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →